Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies, therapies that cure ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 ...

Breakthrough Properties' eight-story life sciences building at 2300 Market St. welcomed a big addition on Thursday.

The FDA has put a clinical hold on a Tenaya Therapeutics gene therapy study | The FDA has put a clinical hold on a Tenaya ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Legend Biotech ( (LEGN)) has provided an ...

The pandemic is having a profound impact on the biotech industry and the way in which it is viewed. How will it change industry perception by the public, patients, and policymakers? What are the ...

Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

Now, let's delve into solving the Biotech crops crossword clue, featured as 49 Down in the USA Today Crossword on November 9, ...

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 millionEC and U.S. FDA label updates for CARVYKTI® to include overall survival benefit versus standard of care Ov ...

RegenLab USA, the American affiliate of a Swiss-based company that leads in medical biotechnologies and specializes in cellular therapies, officially joined the BioBAT life science incubator at the ...